Wanbangde Pharmaceutical Holding Group Co., Ltd. (002082.SZ)
CNY 5.77
(4.15%)
CNY 5.77
(4.15%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.54 Billion | 1.78 Billion | 1.93 Billion | 13.7 Billion | 15.79 Billion | 14.33 Billion |
| Cost of Revenue | 918.17 Million | 847.29 Million | 981.87 Million | 12.34 Billion | 15.08 Billion | 13.81 Billion |
| Gross Profit | 623.75 Million | 939.12 Million | 948.72 Million | 1.35 Billion | 709.65 Million | 522.27 Million |
| Operating Expenses | 596.76 Million | 651.18 Million | 653.19 Million | 860.62 Million | 384.21 Million | 349.32 Million |
| Selling, General and Administrative Expenses | 327.05 Million | 451.31 Million | 458.16 Million | 527.54 Million | 155.25 Million | 136.23 Million |
| Research and Development Expenses | 53.98 Million | 59.1 Million | 76.19 Million | 184.89 Million | 119.72 Million | 99.6 Million |
| Other Expenses | 215.71 Million | 140.76 Million | 118.82 Million | 148.18 Million | 109.23 Million | -2.9 Million |
| Cost and Expenses | 1.51 Billion | 1.49 Billion | 1.63 Billion | 13.2 Billion | 15.46 Billion | 14.16 Billion |
| Operating Income | 26.99 Million | 268.05 Million | 512.68 Million | 513.21 Million | 263.1 Million | 146.05 Million |
| Interest Expense | 47.88 Million | 33.19 Million | 35.6 Million | 56.68 Million | 47.3 Million | 25.88 Million |
| Income Tax Expense | 3.6 Million | 25.81 Million | 199.97 Million | 55.54 Million | 53.75 Million | 17.96 Million |
| Earnings before Tax | 29.93 Million | 100.13 Million | 361.13 Million | 347.75 Million | 262.58 Million | 143.15 Million |
| Net Income | 49.2 Million | 74.32 Million | 166.5 Million | 284.93 Million | 157.02 Million | 84.08 Million |
| Earnings Per Share Basic | 0.08 | 0.12 | 0.27 | 0.47 | 1.24 | 0.35 |
| Earnings Per Share Diluted | 0.08 | 0.12 | 0.27 | 0.47 | 1.24 | 0.35 |
| Weighted Average Shares Outstanding | 615.11 Million | 613.22 Million | 616.7 Million | 606.24 Million | 238 Million | 238 Million |
| Weighted Average Shares Outstanding (Diluted) | 615.11 Million | 613.22 Million | 616.7 Million | 606.24 Million | 238 Million | 240.22 Million |
| Gross Margin | 0.40 | 0.53 | 0.49 | 0.10 | 0.04 | 0.04 |
| EBIT Margin | 0.11 | 0.21 | 0.31 | 0.05 | 0.03 | 0.02 |
| Profit Margin | 0.03 | 0.04 | 0.09 | 0.02 | 0.01 | 0.01 |
| EBITDA | 173.35 Million | 242.3 Million | 494.22 Million | 517.96 Million | 665.99 Million | 238.4 Million |
| Earnings Before Tax Margin | 0.02 | 0.15 | 0.27 | 0.04 | 0.02 | 0.01 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 321.69 Million | 323.62 Million | 429.17 Million | 1.54 Billion | 524.02 Million | 279.34 Million |
| Cost of Revenue | 166.71 Million | 197.85 Million | 273.93 Million | 907.26 Million | 336.3 Million | 126.18 Million |
| Gross Profit | 154.97 Million | 125.77 Million | 155.23 Million | 634.67 Million | 187.72 Million | 153.15 Million |
| Operating Expenses | 158.77 Million | 124.65 Million | 107.12 Million | 524.27 Million | 96.7 Million | 174.66 Million |
| Selling, General and Administrative Expenses | 223.87 Million | 47.51 Million | 108.9 Million | - | -66.13 Million | 218.81 Million |
| Research and Development Expenses | 14.81 Million | 14.38 Million | 13.05 Million | - | 15.07 Million | 11.12 Million |
| Other Expenses | -79.91 Million | -1.28 Million | -218.15 Thousand | 2.93 Million | 4.21 Million | 76.97 Thousand |
| Cost and Expenses | 325.49 Million | 322.5 Million | 381.05 Million | 1.43 Billion | 433 Million | 300.85 Million |
| Operating Income | 16.03 Million | -7.08 Million | 31.46 Million | 26.99 Million | 44.56 Million | -44.27 Million |
| Interest Expense | - | - | - | 46.48 Million | - | 13.66 Million |
| Income Tax Expense | 6.36 Million | -13.46 Million | 6.28 Million | 3.6 Million | 13.76 Million | -6.31 Million |
| Earnings before Tax | 12.56 Million | -8.37 Million | 31.24 Million | 29.93 Million | 48.77 Million | -44.66 Million |
| Net Income | 8 Million | 8.86 Million | 28.83 Million | 49.2 Million | 56.17 Million | -38.55 Million |
| Earnings Per Share Basic | 0.01 | 0.01 | 0.05 | - | 0.09 | -0.06 |
| Earnings Per Share Diluted | 0.01 | 0.01 | 0.05 | - | 0.09 | -0.06 |
| Weighted Average Shares Outstanding | 618.85 Million | 618.85 Million | 618.85 Million | 611.68 Million | 611.68 Million | 611.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 618.85 Million | 618.85 Million | 618.85 Million | 611.68 Million | 611.68 Million | 611.68 Million |
| Gross Margin | 0.48 | 0.39 | 0.36 | 0.41 | 0.36 | 0.55 |
| EBIT Margin | 0.02 | -0.01 | 0.13 | - | 0.16 | -0.05 |
| Profit Margin | 0.02 | 0.03 | 0.07 | 0.03 | 0.11 | -0.14 |
| EBITDA | 5.95 Million | -3.09 Million | 53.85 Million | - | 85.42 Million | -14.72 Million |
| Earnings Before Tax Margin | 0.05 | -0.02 | 0.07 | 0.02 | 0.09 | -0.16 |
STARHEALTH
THRU
OGC
AST
3454
ROAOF